Growth Metrics

GE HealthCare Technologies (GEHC) Cost of Revenue (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Cost of Revenue readings, the most recent being $481.0 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 19.57% to $481.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.8 billion, a 251.93% increase, with the full-year FY2025 number at $3.4 billion, up 78.03% from a year prior.
  • Cost of Revenue hit $481.0 million in Q1 2026 for GE HealthCare Technologies, down from $887.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.1 billion in Q3 2023 to a low of -$5.0 billion in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $751.0 million (2022), compared with a mean of $12.5 million.
  • Biggest five-year swings in Cost of Revenue: tumbled 60.4% in 2024 and later soared 121.56% in 2025.
  • GE HealthCare Technologies' Cost of Revenue stood at -$3.4 billion in 2022, then crashed by 49.27% to -$5.0 billion in 2023, then rose by 17.78% to -$4.1 billion in 2024, then soared by 121.56% to $887.0 million in 2025, then crashed by 45.77% to $481.0 million in 2026.
  • The last three reported values for Cost of Revenue were $481.0 million (Q1 2026), $887.0 million (Q4 2025), and $884.0 million (Q3 2025) per Business Quant data.